Lalantha Leelarathna

Author

Also Known As

L Leelarathna, L. H. Leelarathna, L. Leelarathna, LALANTHA LEELARATHNA, Lala Leelarathna, Lalantha Leelarathna, Leelarathna L, Leelarathna, L, Leelarathna, Lalantha, Leelarathna, L

179

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Wellcome Trust Wellcome/MRC Institute of Metabolic Science Manchester University NHS Foundation Trust Manchester Academic Health Science Centre

About

Lalantha Leelarathna is an author at University of Cambridge specializing in diabetes, medicine, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Diabetes	13	13	1.2K
2	Medicine	11	11	1K
3	Public Health	6	6	557
4	Health Sciences	2	2	275
5	Biomedical Engineering	1	1	364

Lalantha Leelarathna

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Home Use of an Artificial Beta Cell in Type 1 Diabetes Hood Thabit, Martin Tauschmann, Janet M. Allen, New England Journal of Medicine	2015	447
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial Martin Tauschmann, Hood Thabit, Lia Bally, The Lancet	2018	420
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice Moshe Phillip, Revital Nimri, Richard M. Bergenstal, Endocrine Reviews Biomedical EngineeringArtificial PancreasAid SystemsPublic HealthInsulin Delivery	2022	364
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings David C. Klonoff, Jing Wang, David Rodbard, Journal of Diabetes Science and Technology	2022	254
Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS) Stuart Little, Lalantha Leelarathna, Emma Walkinshaw, Diabetes Care	2014	228
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care Matthew Carr, Alison K. Wright, Lalantha Leelarathna, BMJ Quality & Safety	2021	221
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial Roman Hovorka, Daniela Elleri, Hood Thabit, Diabetes Care	2014	216
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA) Othmar Moser, Michael C. Riddell, Max L. Eckstein, Diabetologia Metabolic SyndromeType 1Physical ActivityKinesiologyDiabetes Management	2020	196
Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study Julia Lawton, Maxine Blackburn, Jody L. Allen, BMC Endocrine Disorders	2018	168
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents Katharine Barnard, Tim Wysocki, Janet M. Allen, BMJ Open Diabetes Research & Care	2014	158

Page 1